1. Home
  2. LIDR vs MRSN Comparison

LIDR vs MRSN Comparison

Compare LIDR & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$2.19

Market Cap

118.0M

ML Signal

HOLD

Logo Mersana Therapeutics Inc.

MRSN

Mersana Therapeutics Inc.

HOLD

Current Price

$29.22

Market Cap

138.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
MRSN
Founded
2013
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
138.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LIDR
MRSN
Price
$2.19
$29.22
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$6.00
$30.38
AVG Volume (30 Days)
1.4M
114.7K
Earning Date
02-19-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$182,000.00
$33,180,000.00
Revenue This Year
$2.76
N/A
Revenue Next Year
$2,830.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$5.21
52 Week High
$6.44
$36.25

Technical Indicators

Market Signals
Indicator
LIDR
MRSN
Relative Strength Index (RSI) 47.60 78.89
Support Level $2.09 $28.11
Resistance Level $2.32 $29.15
Average True Range (ATR) 0.13 0.57
MACD 0.00 -0.47
Stochastic Oscillator 61.61 48.68

Price Performance

Historical Comparison
LIDR
MRSN

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Share on Social Networks: